PIGN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.706200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.148400E-01
Normal-vs-Stage2
2.481200E-01
Normal-vs-Stage3
1.918420E-01
Normal-vs-Stage4
4.510600E-01
Stage1-vs-Stage2
4.258600E-01
Stage1-vs-Stage3
8.524200E-02
Stage1-vs-Stage4
6.512600E-01
Stage2-vs-Stage3
3.9030000000051E-05
Stage2-vs-Stage4
9.723400E-01
Stage3-vs-Stage4
2.184800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.554800E-01
Normal-vs-AfricanAmerican
9.584800E-01
Normal-vs-Asian
6.102100E-02
Caucasian-vs-AfricanAmerican
1.351020E-01
Caucasian-vs-Asian
7.623900E-02
AfricanAmerican-vs-Asian
2.044200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.245400E-01
Normal-vs-Female
3.538800E-01
Male-vs-Female
2.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.361400E-01
Normal-vs-Age(41-60Yrs)
5.188400E-01
Normal-vs-Age(61-80Yrs)
2.069600E-01
Normal-vs-Age(81-100Yrs)
1.801620E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.012200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.349800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.852200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.241600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.186000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.977000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.130010E-01
Normal-vs-Daily Drinker
2.611900E-02
Normal-vs-Weekly Drinker
1.582780E-01
Normal-vs-Occasional Drinker
4.890800E-01
Normal-vs-Social Drinker
7.275400E-01
Non Drinker-vs-Daily Drinker
1.342550E-01
Non Drinker-vs-Weekly Drinker
6.520400E-01
Non Drinker-vs-Occasional Drinker
9.414200E-02
Non Drinker-vs-Social Drinker
1.456620E-01
Daily Drinker-vs-Weekly Drinker
4.741600E-01
Daily Drinker-vs-Occasional Drinker
4.983200E-03
Daily Drinker-vs-Social Drinker
2.523500E-02
Weekly Drinker-vs-Occasional Drinker
1.013170E-01
Weekly Drinker-vs-Social Drinker
1.223240E-01
Occasional Drinker-vs-Social Drinker
7.486600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.610300E-02
Normal-vs-Grade 2
2.934500E-02
Normal-vs-Grade 3
1.665870E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.925200E-01
Grade 1-vs-Grade 3
9.273000E-01
Grade 1-vs-Grade 4
7.610300E-02
Grade 2-vs-Grade 3
1.570820E-01
Grade 2-vs-Grade 4
2.934500E-02
Grade 3-vs-Grade 4
1.665870E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.585380E-01
Normal-vs-NonDiabetic
1.617350E-01
Diabetic-vs-NonDiabetic
4.510400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.770000E-02
Normal-vs-NoPancreatitis
1.934220E-01
Pancreatitis-vs-NoPancreatitis
1.086230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.871000E-01
Normal-vs-N1
2.354000E-01
N0-vs-N1
9.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.711620E-01
Normal-vs-TP53-NonMutant
7.466600E-01
TP53-Mutant-vs-TP53-NonMutant
5.444800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
